Literature DB >> 11854425

Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.

Cédric Blanpain1, Jean-Marie Vanderwinden, Josef Cihak, Valérie Wittamer, Emmanuel Le Poul, Hassan Issafras, Manfred Stangassinger, Gilbert Vassart, Stefano Marullo, Detlef Schlndorff, Marc Parmentier, Matthias Mack.   

Abstract

CC-chemokine receptor 5 (CCR5) is the principal coreceptor for macrophage-tropic strains of human immunodeficiency virus type 1 (HIV-1). We have generated a set of anti-CCR5 monoclonal antibodies and characterized them in terms of epitope recognition, competition with chemokine binding, receptor activation and trafficking, and coreceptor activity. MC-4, MC-5, and MC-7 mapped to the amino-terminal domain, MC-1 to the second extracellular loop, and MC-6 to a conformational epitope covering multiple extracellular domains. MC-1 and MC-6 inhibited regulated on activation normal T cell expressed and secreted (RANTES), macrophage inflammatory polypeptide-1beta, and Env binding, whereas MC-5 inhibited macrophage inflammatory polypeptide-1beta and Env but not RANTES binding. MC-6 induced signaling in different functional assays, suggesting that this monoclonal antibody stabilizes an active conformation of CCR5. Flow cytometry and real-time confocal microscopy showed that MC-1 promoted strong CCR5 endocytosis. MC-1 but not its monovalent isoforms induced an increase in the transfer of energy between CCR5 molecules. Also, its monovalent isoforms bound efficiently, but did not internalize the receptor. In contrast, MC-4 did not prevent RANTES binding or subsequent signaling, but inhibited its ability to promote CCR5 internalization. These results suggest the existence of multiple active conformations of CCR5 and indicate that CCR5 oligomers are involved in an internalization process that is distinct from that induced by the receptor's agonists.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854425      PMCID: PMC65662          DOI: 10.1091/mbc.01-03-0129

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  64 in total

1.  Involvement of the amino terminus of the B(2) receptor in agonist-induced receptor dimerization.

Authors:  S AbdAlla; E Zaki; H Lother; U Quitterer
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

Review 2.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

3.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

Authors:  M Rocheville; D C Lange; U Kumar; S C Patel; R C Patel; Y C Patel
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

4.  Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.

Authors:  M Rocheville; D C Lange; U Kumar; R Sasi; R C Patel; Y C Patel
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

5.  CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

Authors:  L Lopalco; C Barassi; C Pastori; R Longhi; S E Burastero; G Tambussi; F Mazzotta; A Lazzarin; M Clerici; A G Siccardi
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

6.  Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state.

Authors:  W G Thomas; H Qian; C S Chang; S Karnik
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

7.  G-protein-coupled receptors function as oligomers in vivo.

Authors:  M C Overton; K J Blumer
Journal:  Curr Biol       Date:  2000-03-23       Impact factor: 10.834

8.  Membrane raft microdomains mediate front-rear polarity in migrating cells.

Authors:  S Mañes; E Mira; C Gómez-Moutón; R A Lacalle; P Keller; J P Labrador; C Martínez-A
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

9.  HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.

Authors:  A J Vila-Coro; M Mellado; A Martín de Ana; P Lucas; G del Real; C Martínez-A; J M Rodríguez-Frade
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).

Authors:  S Angers; A Salahpour; E Joly; S Hilairet; D Chelsky; M Dennis; M Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  55 in total

1.  Video views and reviews.

Authors:  Christopher Watters
Journal:  Cell Biol Educ       Date:  2002

2.  Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor.

Authors:  José Miguel Rodríguez-Frade; Gustavo del Real; Antonio Serrano; Patricia Hernanz-Falcón; Silvia F Soriano; Antonio J Vila-Coro; Ana Martín de Ana; Pilar Lucas; Ignacio Prieto; Carlos Martínez-A; Mario Mellado
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

3.  Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7.

Authors:  C Ullmer; S Zoffmann; B Bohrmann; H Matile; L Lindemann; Pj Flor; P Malherbe
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Conformation state-sensitive antibodies to G-protein-coupled receptors.

Authors:  Achla Gupta; Fabien M Décaillot; Ivone Gomes; Oleg Tkalych; Andrea S Heimann; Emer S Ferro; Lakshmi A Devi
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

5.  Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody.

Authors:  Andrii Ishchenko; Daniel Wacker; Mili Kapoor; Ai Zhang; Gye Won Han; Shibom Basu; Nilkanth Patel; Marc Messerschmidt; Uwe Weierstall; Wei Liu; Vsevolod Katritch; Bryan L Roth; Raymond C Stevens; Vadim Cherezov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

Review 6.  Antibodies against G-protein coupled receptors: novel uses in screening and drug development.

Authors:  Achla Gupta; Andrea S Heimann; Ivone Gomes; Lakshmi A Devi
Journal:  Comb Chem High Throughput Screen       Date:  2008-07       Impact factor: 1.339

7.  Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.

Authors:  Claudia Pastori; Barbara Weiser; Claudia Barassi; Caterina Uberti-Foppa; Silvia Ghezzi; Renato Longhi; Giliola Calori; Harold Burger; Kimdar Kemal; Guido Poli; Adriano Lazzarin; Lucia Lopalco
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

8.  Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.

Authors:  Hubert Gaertner; Fabrice Cerini; Jean-Michel Escola; Gabriel Kuenzi; Astrid Melotti; Robin Offord; Irène Rossitto-Borlat; Rebecca Nedellec; Janelle Salkowitz; Guy Gorochov; Donald Mosier; Oliver Hartley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

9.  The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIV.

Authors:  Moria Shimoni; Alon Herschhorn; Yelena Britan-Rosich; Moshe Kotler; Itai Benhar; Amnon Hizi
Journal:  Viral Immunol       Date:  2013-08       Impact factor: 2.257

Review 10.  Chemokines and their receptors in the allergic airway inflammatory process.

Authors:  Juan Raymundo Velazquez; Luis Manuel Teran
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.